Functional magnetic resonance Imaging GUided Radiation therapy dose Escalation in Head and Neck Cancer (FIGURE-rad HNC)

Not Applicable

• Conditions: Head and Neck Cancer; Cancer - Head and neck

• Registration Number: ACTRN12620000534987
• Lead Sponsor: Dr Myo Min

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-04-30
• Last Update Posted: 25 May 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Histologically confirmed primary squamous cell carcinoma of the head and neck region
- Not fit for, or declined surgical resection and/or chemotherapy, or unresectable disease
- Able to give informed consent to treatment by understanding the nature, significances and consequences of the study

Exclusion Criteria

- Previous radiation therapy to the head and neck region
- Evidence of metastatic disease
- Contraindication to MRI such as significant claustrophobia, pacemaker/defibrillator or implanted metals
- ECOG performance status greater than 2 or KPS less than 60
- Life expectancy likely less than 12 months due to other significant comorbidities
- Simultaneous participation in another interventional trial that may interfere with the results of this trial

Study & Design

• Study Type: Interventional
• Study Design: Not specified